9723237

Source:http://linkedlifedata.com/resource/pubmed/id/9723237

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0005767, umls-concept:C0010592, umls-concept:C0018823, umls-concept:C0021149, umls-concept:C0026565, umls-concept:C0035015, umls-concept:C0205178, umls-concept:C0439234, umls-concept:C0441889, umls-concept:C1548437, umls-concept:C1882923
pubmed:issue	5
pubmed:dateCreated	1998-9-24
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0243532
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Cyclosporine, http://linkedlifedata.com/resource/pubmed/chemical/Immunosuppressive Agents, http://linkedlifedata.com/resource/pubmed/chemical/Methylprednisolone, http://linkedlifedata.com/resource/pubmed/chemical/Muromonab-CD3
pubmed:status	MEDLINE
pubmed:month	Aug
pubmed:issn	0041-1345
pubmed:author	pubmed-author:DelgadoJ FJF, pubmed-author:EscribanoPP, pubmed-author:Gómez-SánchezM AMA, pubmed-author:GilRR, pubmed-author:Hernández-AfonsoJJ, pubmed-author:OrtuñoBB, pubmed-author:RodriguezJ EJE, pubmed-author:RomeroFF, pubmed-author:RufilanchasJ JJJ, pubmed-author:Sáenz de la CalzadaCC, pubmed-author:SantosMM, pubmed-author:SoteloTT
pubmed:issnType	Print
pubmed:volume	30
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1671-2
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:9723237-Cyclosporine, pubmed-meshheading:9723237-Drug Monitoring, pubmed-meshheading:9723237-Drug Therapy, Combination, pubmed-meshheading:9723237-Female, pubmed-meshheading:9723237-Graft Rejection, pubmed-meshheading:9723237-Heart Transplantation, pubmed-meshheading:9723237-Hemodynamics, pubmed-meshheading:9723237-Humans, pubmed-meshheading:9723237-Immunosuppressive Agents, pubmed-meshheading:9723237-Incidence, pubmed-meshheading:9723237-Male, pubmed-meshheading:9723237-Methylprednisolone, pubmed-meshheading:9723237-Middle Aged, pubmed-meshheading:9723237-Muromonab-CD3, pubmed-meshheading:9723237-Postoperative Period, pubmed-meshheading:9723237-Retrospective Studies, pubmed-meshheading:9723237-Survival Rate, pubmed-meshheading:9723237-Time Factors
pubmed:year	1998
pubmed:articleTitle	Early cyclosporine blood levels impact the incidence of acute rejection and overall mortality in the first year after heart transplantation.
pubmed:affiliation	Heart Failure and Transplantation Program, Hospital 12 de Octubre, Madrid, Spain.
pubmed:publicationType	Journal Article